JPH0636750B2 - Method for concentrated preparation of milk ganglioside - Google Patents

Method for concentrated preparation of milk ganglioside

Info

Publication number
JPH0636750B2
JPH0636750B2 JP10311487A JP10311487A JPH0636750B2 JP H0636750 B2 JPH0636750 B2 JP H0636750B2 JP 10311487 A JP10311487 A JP 10311487A JP 10311487 A JP10311487 A JP 10311487A JP H0636750 B2 JPH0636750 B2 JP H0636750B2
Authority
JP
Japan
Prior art keywords
ganglioside
milk
solution
gangliosides
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP10311487A
Other languages
Japanese (ja)
Other versions
JPS63269992A (en
Inventor
修一 柳平
吾朗 花形
栄記 出家
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Snow Brand Milk Products Co Ltd
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Priority to JP10311487A priority Critical patent/JPH0636750B2/en
Publication of JPS63269992A publication Critical patent/JPS63269992A/en
Publication of JPH0636750B2 publication Critical patent/JPH0636750B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Dairy Products (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は、元来牛乳に含まれているガングリオシドを種
々の乳質物質を出発原料として用い、これから高含有の
ガングリオシドを有利に濃縮調製する方法に関する。
DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) The present invention is a method for advantageously concentrating a high content ganglioside from ganglioside originally contained in milk using various dairy substances as starting materials. Regarding

(従来の技術とその問題点) 近年、ガングリオシドの生物学的研究が盛んになり、神
経機能、ガン化、ウイルス感染、分化、増殖、ホルモン
セプターなどの医学、薬学面におけるガングリオシドの
研究が重要になってきている。特に、ガングリオシド
は、細胞表面に局在する特異な活性物質として注目され
ている。
(Prior art and its problems) In recent years, biological research on gangliosides has become popular, and research on gangliosides in the fields of medicine and pharmacy such as nerve function, canceration, viral infection, differentiation, proliferation, hormone sceptor, etc. becomes important. It has become to. In particular, ganglioside has been attracting attention as a unique active substance localized on the cell surface.

ガングリオシドは、動物の脳などに多く存在することが
知られている物質であるが、牛乳中にも比較的多く存在
している。
Ganglioside is a substance known to be present in large amounts in the brain of animals, but is also present in milk in relatively large amounts.

牛乳ガングリオシドについては、永井ら(脂質化学研究
27、182〜185(1985))により形態が明らかにされてお
り、また調製法に関しては、最近毒素の中和剤として特
許出願されている(特開昭60-72819)。この方法は、バ
ターミルクから脂肪球皮膜を得る方法であるが、蛋白質
含有量が高く、ガングリオシドは高濃度では得られてい
ない。
For milk ganglioside, see Nagai et al.
27 , 182-185 (1985)), and its preparation method has recently been applied for a patent as a neutralizing agent for toxins (JP-A-60-72819). This method is a method for obtaining a fat globule membrane from buttermilk, but the protein content is high, and ganglioside is not obtained at a high concentration.

このほかに、現状では高濃度のガングリオシドを得る方
法は知られておらず、牛乳ガングリオシドを工業的規模
で調製することは困難であり、容易でないとされてい
た。
In addition to this, at present, there is no known method for obtaining a high concentration of ganglioside, and it has been considered difficult to prepare milk ganglioside on an industrial scale, and it is not easy.

従って、乳質物質に含まれるガングリオシドを効率よ
く、有利に濃縮調製し、高濃度のガングリオシドを得る
方法の開発が望まれていた。
Therefore, it has been desired to develop a method for efficiently and advantageously concentrating ganglioside contained in a milk substance to obtain a high concentration of ganglioside.

本発明は、ガングリオシドを含有する乳質物質を出発原
料として用い、これからガングリオシドを効率よく濃縮
調製する方法を提供することを目的とする。
It is an object of the present invention to provide a method for efficiently concentrating and preparing ganglioside from a milk substance containing ganglioside as a starting material.

(問題点を解決するための手段) 本発明は、牛乳ガングリオシドを含む乳質物質に蛋白質
分解酵素を作用させて蛋白質を分解し、得られた蛋白質
分解溶液を濾過し、ガングリオシドを濃縮することを特
徴とする。
(Means for Solving Problems) The present invention is characterized in that a dairy substance containing milk ganglioside is reacted with a proteolytic enzyme to decompose the protein, and the resulting proteolytic solution is filtered to concentrate the ganglioside. And

前記濾過は、限外濾過法あるいはゲル濾過法で行うこと
が好ましい。この他に透析法も利用できる。
The filtration is preferably performed by an ultrafiltration method or a gel filtration method. Besides this, a dialysis method can also be used.

本発明において、出発原料として用いる乳質物質として
は、牛乳、および牛乳から得られるバターミルク、ホエ
ー、脱脂乳等が挙げられる。
In the present invention, examples of the dairy substance used as a starting material include milk, buttermilk obtained from milk, whey, skim milk, and the like.

これら乳質物質は、ガングリオシド以外に蛋白質、乳
糖、脂質などを含有するため、これらを除く必要があ
る。
These dairy substances contain proteins, lactose, lipids, etc. in addition to gangliosides, and therefore these substances must be removed.

蛋白質を除くには、蛋白質分解酵素を用い、ペプチドあ
るいはアミノ酸まで分解する。この蛋白質分解酵素とし
て、トリプシン、ペプシン、キモトリプシン、パパイ
ン、タカジアスターゼ、枯草菌プロテアーゼなどを例示
し得る。反応条件は、例えば原料の乳質物質中の蛋白質
濃度に対して、蛋白質分解酵素を0.1から10重量%にな
るように添加し、pH2〜10、温度20〜60℃の範囲内で3
〜100時間で反応させることが好ましい。
To remove proteins, proteolytic enzymes are used to decompose peptides or amino acids. Examples of this proteolytic enzyme include trypsin, pepsin, chymotrypsin, papain, takadiastase, and Bacillus subtilis protease. The reaction conditions are, for example, 3% within the range of pH 2-10 and temperature 20-60 ° C by adding proteolytic enzyme to 0.1 to 10% by weight with respect to the protein concentration in the raw material milk substance.
It is preferable to carry out the reaction in about 100 hours.

このようにして、乳質物質中の蛋白質を分解して得た溶
液を、90〜100℃で数分間加熱し、酵素を失活させる。
In this way, the solution obtained by decomposing the protein in the milk substance is heated at 90 to 100 ° C. for several minutes to inactivate the enzyme.

次に、この溶液を限外濾過法、ゲル濾過法あるいは透析
法等で処理し、濃縮したガングリオシドを得る。
Next, this solution is treated by an ultrafiltration method, a gel filtration method, a dialysis method or the like to obtain a concentrated ganglioside.

限外濾過法は、大きい溶質分子を小さい溶質分子や溶媒
分子からふるい分ける分子レベルの濾過法である。この
方法でガングリオシドを濃縮するには、限外濾過膜を装
着した装置を用いる。この装置を用いると、濃縮槽にガ
ングリオシドが濃縮され、溶出液からは、蛋白質分解酵
素により分解されたペプチド、アミノ酸、乳糖その他の
低分子物質が除かれる。限外濾過膜膜としては、2千か
ら50万の分画分子量のもの、例えば透析膜あるいはDD
S社製GR−51Pが利用できる。
The ultrafiltration method is a molecular-level filtration method that screens large solute molecules from small solute molecules and solvent molecules. To concentrate gangliosides by this method, an apparatus equipped with an ultrafiltration membrane is used. Using this device, gangliosides are concentrated in the concentration tank, and peptides, amino acids, lactose, and other low-molecular substances decomposed by proteolytic enzymes are removed from the eluate. The ultrafiltration membrane has a molecular weight cut off of 2,000 to 500,000, such as dialysis membrane or DD.
GR-51P manufactured by S company can be used.

ゲル濾過法は、高分子溶質と低分子溶質とを含む溶液
を、溶媒で膨潤させたゲル粒子のカラムに添加し、溶媒
を流し、高分子溶質と遅れて溶出される低分子溶質を分
離する方法である。この方法では、蛋白質分解溶液をゲ
ル濾過カラムに流し、ボイド画分に濃縮されたガングリ
オシドを得る。ゲルには、通常使用される例えばセファ
デックス、バイオゲル、アガロースゲル等が用いられ
る。
In the gel filtration method, a solution containing a high molecular solute and a low molecular solute is added to a column of gel particles swollen with a solvent, the solvent is allowed to flow, and the high molecular solute and the low molecular solute to be eluted later are separated. Is the way. In this method, the proteolytic solution is passed through a gel filtration column to obtain concentrated gangliosides in the void fraction. As the gel, commonly used ones such as Sephadex, biogel, agarose gel and the like are used.

このようして得られた濃縮液を回収し、乾燥して、高含
有ガングリオシド粉末を得る。
The concentrated solution thus obtained is collected and dried to obtain a high content ganglioside powder.

上述のようにして得た粉末中のガングリオシド含量は、
乳質物質によって異なるが、通常は0.5〜5%含有す
る。さらにガングリオシドの純度を高めるには、従来か
ら知られている方法、例えばイオン交換樹脂にガングリ
オシドを吸着し、溶出した後、シリカゲルクロマトグラ
フィーで分離・精製して単一分子種とする等の方法を用
いることができる。
The ganglioside content in the powder obtained as described above is
Although it depends on the dairy substance, it is usually contained in an amount of 0.5 to 5%. In order to further increase the purity of ganglioside, a conventionally known method, for example, a method of adsorbing ganglioside on an ion exchange resin, eluting it, and then separating and purifying by silica gel chromatography to obtain a single molecular species, etc. Can be used.

(発明の効果) 本発明は、乳質物質に含まれる牛乳ガングリオシドを新
規な濃縮調製法、即ち、蛋白質分解酵素を用い蛋白質を
分解し、限外濾過法、ゲル濾過法あるいは透析法等によ
り、濃縮調製する方法を用いたので、ガングリオシドを
効率よく有利に濃縮調製し、高濃度のガングリオシドを
工業的規模で調製することができた。
(Effect of the invention) The present invention is a novel method for concentrating milk ganglioside contained in a milk substance, that is, degrading a protein using a proteolytic enzyme, and concentrating the protein by an ultrafiltration method, a gel filtration method, a dialysis method, or the like. Since the method of preparation was used, gangliosides could be efficiently and advantageously concentrated and prepared, and a high concentration of gangliosides could be prepared on an industrial scale.

なお、ガングリオシドは、一般に蛋白質と複合体を形成
しており、この結果を切るには、アルコールを含む有機
溶媒が必須とされている。
It should be noted that ganglioside generally forms a complex with a protein, and an organic solvent containing alcohol is essential for cutting off the result.

しかし本発明においては、これらアルコールなどを必要
とせずに濃縮調製することが可能となった。
However, in the present invention, it has become possible to concentrate and prepare without the need for these alcohols.

(実施例) 以下、実施例により本発明を具体的に説明する。(Examples) Hereinafter, the present invention will be specifically described with reference to Examples.

実施例1 バターミルク粉20kgを水180に溶解した溶液に、0.5kg
の枯草菌プロテアーゼを添加し、pH7.6、温度40℃で15
時間反応させ、蛋白質を分解した後、90℃で10分間加熱
し、酵素を失活させた。
Example 1 0.5 kg of a solution prepared by dissolving 20 kg of buttermilk powder in 180 water
Bacillus subtilis protease is added to the solution at pH 7.6 at a temperature of 40 ° C for 15
After reacting for a time to decompose the protein, it was heated at 90 ° C. for 10 minutes to inactivate the enzyme.

次いで、この溶液を、GR-51P(DDS社製)の膜面積0.
36m2の濾過膜を装着した限外濾過装置(LAB−20型
モジュール、DDS社製)にて、温度40℃、流量15/
分、平均圧力0.6MPaで濾過し、ガングリオシドを濃縮し
た。濃縮終了後、濃縮槽より濃縮液を回収し、凍結乾燥
を行って、粉末1400gを得た。
Then, this solution was added to a membrane area of GR-51P (manufactured by DDS) of 0.
Using an ultrafiltration device (LAB-20 type module, manufactured by DDS) equipped with a 36 m 2 filtration membrane, temperature 40 ° C., flow rate 15 /
Minutes, the mixture was filtered at an average pressure of 0.6 MPa to concentrate the ganglioside. After the concentration was completed, the concentrated liquid was collected from the concentration tank and freeze-dried to obtain 1400 g of powder.

このようにして得られた粉末は、ガングリオシドを2.0
%(但し、シアル酸に換算した)含有していた。
The powder thus obtained contained 2.0% gangliosides.
% (However, converted to sialic acid).

実施例2 牛乳50にトリプシンを150g添加し、pH7.6、温度40℃
で24時間蛋白質を分解した後、90℃で10分間加熱し、酵
素を失活させた。
Example 2 To milk 50, 150 g of trypsin was added, pH 7.6, temperature 40 ° C.
After decomposing the protein for 24 hours at 90 ° C., the enzyme was inactivated by heating at 90 ° C. for 10 minutes.

次いで、この溶液を、HW-55(Toyo Soda社製)を充填し
たゲル濾過カラム(60×100cm)に流し、ガングリオシ
ドが濃縮されているボイド画分を回収し、凍結乾燥を行
って、粉末1200gを得た。
Then, this solution was passed through a gel filtration column (60 × 100 cm) packed with HW-55 (manufactured by Toyo Soda), and a void fraction in which ganglioside was concentrated was collected and freeze-dried to obtain 1200 g of a powder. Got

このようにして得られた粉末は、ガングリオシドを0.5
%(但し、シアル酸に換算した)含有していた。
The powder thus obtained contained 0.5% gangliosides.
% (However, converted to sialic acid).

実施例3 実施例1および実施例2により調製した高含有ガングリ
オシド粉末1kgにクロロホルム−メタノール混液(1:
1)を10加え、室温で30分間攪拌し、抽出した。
Example 3 1 kg of high-content ganglioside powder prepared according to Example 1 and Example 2 was mixed with a chloroform-methanol mixture (1:
10) of 1) was added, and the mixture was stirred at room temperature for 30 minutes and extracted.

次に、クロロホルム−メタノール混液を回収し、イオン
交換樹脂(DEAE-Toyopearlアセテート型)1に流して
ガングリオシドを吸着させ、次いで、クロロヘルム−メ
タノール混液(1:1)2で樹脂を洗浄したのち、0.
5モル酢酸ナトリウム−メタノール溶液4でガングリ
オシドを溶出した。溶出液を濃縮し、メタノールを除去
した後、水5を加えて限外濾過膜(GR-61pp、DDS
社製)で、脱塩とガングリオシドの濃縮を行った。
Next, the chloroform-methanol mixed solution was collected and passed through an ion exchange resin (DEAE-Toyopearl acetate type) 1 to adsorb ganglioside, and then the resin was washed with a chlorohelm-methanol mixed solution (1: 1) 2 and then 0 .
Gangliosides were eluted with 5 molar sodium acetate-methanol solution 4. After concentrating the eluate and removing methanol, water 5 was added to the ultrafiltration membrane (GR-61pp, DDS
Desalination and concentration of ganglioside were performed.

ガングリオシドを含む濃縮液をエバポレーターで乾固し
た後、シリカゲルカラム(4.0×50cm)に流し、ガング
リオシドを吸着させ、次いでクロロホルム1、クロロ
ホルム−メタノール混液(4:1)1で順次洗浄した
後、クロロホルム:メタノール(2:8)の混液2で
ガングリオシドを溶出した。溶出液をエバポレータで蒸
発乾固し、白色粉末15gを得た。
The concentrated solution containing ganglioside was dried with an evaporator, and then passed through a silica gel column (4.0 × 50 cm) to adsorb ganglioside, and then sequentially washed with chloroform 1 and chloroform-methanol mixed solution (4: 1) 1, followed by chloroform: The ganglioside was eluted with a mixed solution 2 of methanol (2: 8). The eluate was evaporated to dryness with an evaporator to obtain 15 g of white powder.

このようにして得られた粉末のガングリオシドの純度は
薄膜クロマトグラフィーで90%以上(レゾルシノール
法)であった。
The purity of the thus-obtained powder ganglioside was 90% or more (resorcinol method) by thin film chromatography.

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】牛乳ガングリオシドを含む乳質物質に蛋白
質分解酵素を作用させて蛋白質を分解し、得られた蛋白
質分解溶液を処理し、ガングリオシドを濃縮することを
特徴とする牛乳ガングリオシドの濃縮調製法。
1. A method for concentrating milk ganglioside, which comprises concentrating the ganglioside by treating a milk substance containing milk ganglioside with a proteolytic enzyme to decompose the protein and treating the resulting proteolytic solution.
【請求項2】処理を限外濾過法、ゲル濾過法あるいは透
析法で行う特許請求の範囲第1項記載の牛乳ガングリオ
シドの濃縮調製法。
2. The method for concentrated preparation of milk ganglioside according to claim 1, wherein the treatment is carried out by an ultrafiltration method, a gel filtration method or a dialysis method.
JP10311487A 1987-04-28 1987-04-28 Method for concentrated preparation of milk ganglioside Expired - Fee Related JPH0636750B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10311487A JPH0636750B2 (en) 1987-04-28 1987-04-28 Method for concentrated preparation of milk ganglioside

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10311487A JPH0636750B2 (en) 1987-04-28 1987-04-28 Method for concentrated preparation of milk ganglioside

Publications (2)

Publication Number Publication Date
JPS63269992A JPS63269992A (en) 1988-11-08
JPH0636750B2 true JPH0636750B2 (en) 1994-05-18

Family

ID=14345572

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10311487A Expired - Fee Related JPH0636750B2 (en) 1987-04-28 1987-04-28 Method for concentrated preparation of milk ganglioside

Country Status (1)

Country Link
JP (1) JPH0636750B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11425915B2 (en) 2018-05-02 2022-08-30 Land O'lakes, Inc. Methods of concentrating phospholipids

Also Published As

Publication number Publication date
JPS63269992A (en) 1988-11-08

Similar Documents

Publication Publication Date Title
EP0556083B1 (en) Process for the production of biologically active substances from milk and related raw materials
US5233033A (en) Method for production of sialic acid
JP2622686B2 (en) Method for producing k-casein glycomacropeptide
GB2179947A (en) Process for the extraction of proteins from milk
JPH05238948A (en) Large-scale production of lactoferricin
JP2974434B2 (en) Secretory component-containing composition
US6001974A (en) Method of separating albumin from serum by ion-exchange chromatography with membrane adsorbers
JP2678653B2 (en) Ganglioside extraction and concentration method
JPH0636750B2 (en) Method for concentrated preparation of milk ganglioside
US5290685A (en) Method for separation and concentration of phosphopeptides
JP2782347B2 (en) Concentration and purification method of neutral glycosphingolipid
JPH03262495A (en) Production of highly purified sialic acid of liberating type
JPS62259596A (en) Purification of hybrid protein
JPS6160050B2 (en)
EP0443718B1 (en) Method for separation and concentration of phosphopeptides
JPH07155194A (en) Method for purifying protein
JPH0147997B2 (en)
SU1671691A1 (en) Method for preparation of -n-acetylglucoseaminidase of bacillus subtilis vkpm v-2471
RU2356560C1 (en) Ceruloplasmin recovery method
US3424654A (en) Recovery of micrococcal nuclease
KR930008097B1 (en) Process for preparing colony forming stimulative factor
JPS6157290B2 (en)
JPS63132898A (en) Separation and purification of protein
JPH02299593A (en) Preparation of sphingoglycolipid
SU957835A1 (en) Method of producing aminoacid and lower peptide mixture

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees